Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.3.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.3.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBTEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBTEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBTECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XBTECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBTEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBTEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBTENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBTENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.12EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.12ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.1.12ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.1.12EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.1.12EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.1.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.33EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BQ.1.33EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.33ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BQ.1.33ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BQ.1.33EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BQ.1.33EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BQ.1.33ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.33ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.29EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.29ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.29ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBF.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBF.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBF.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBF.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBF.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBF.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBPEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
XBPEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBPECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
XBPECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBPEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBPEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBPENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBPENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used